CN102018663A - 一种化合物/葡萄糖制剂 - Google Patents

一种化合物/葡萄糖制剂 Download PDF

Info

Publication number
CN102018663A
CN102018663A CN2009102327515A CN200910232751A CN102018663A CN 102018663 A CN102018663 A CN 102018663A CN 2009102327515 A CN2009102327515 A CN 2009102327515A CN 200910232751 A CN200910232751 A CN 200910232751A CN 102018663 A CN102018663 A CN 102018663A
Authority
CN
China
Prior art keywords
formula
preparation
glucose
compound
compound hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009102327515A
Other languages
English (en)
Chinese (zh)
Inventor
吕伏生
李守忠
杨振伟
刘雪芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANTONG JINGHUA BIOLOGICAL ENGINEERING Co Ltd
Original Assignee
NANTONG JINGHUA BIOLOGICAL ENGINEERING Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANTONG JINGHUA BIOLOGICAL ENGINEERING Co Ltd filed Critical NANTONG JINGHUA BIOLOGICAL ENGINEERING Co Ltd
Priority to CN2009102327515A priority Critical patent/CN102018663A/zh
Priority to PCT/CN2010/001875 priority patent/WO2011063605A1/fr
Publication of CN102018663A publication Critical patent/CN102018663A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2009102327515A 2009-11-30 2009-11-30 一种化合物/葡萄糖制剂 Pending CN102018663A (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2009102327515A CN102018663A (zh) 2009-11-30 2009-11-30 一种化合物/葡萄糖制剂
PCT/CN2010/001875 WO2011063605A1 (fr) 2009-11-30 2010-11-22 Préparation de composé/glucose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102327515A CN102018663A (zh) 2009-11-30 2009-11-30 一种化合物/葡萄糖制剂

Publications (1)

Publication Number Publication Date
CN102018663A true CN102018663A (zh) 2011-04-20

Family

ID=43860718

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102327515A Pending CN102018663A (zh) 2009-11-30 2009-11-30 一种化合物/葡萄糖制剂

Country Status (2)

Country Link
CN (1) CN102018663A (fr)
WO (1) WO2011063605A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102101865A (zh) * 2009-12-22 2011-06-22 江苏九寿堂生物制品有限公司 一种喹诺酮类化合物盐酸盐的结晶形式
CN106109407A (zh) * 2016-08-25 2016-11-16 安徽环球药业股份有限公司 盐酸安妥沙星氯化钠注射液的配制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101081210A (zh) * 2006-06-02 2007-12-05 严明 一种喹诺酮类抗生素的注射制剂

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102101865A (zh) * 2009-12-22 2011-06-22 江苏九寿堂生物制品有限公司 一种喹诺酮类化合物盐酸盐的结晶形式
CN106109407A (zh) * 2016-08-25 2016-11-16 安徽环球药业股份有限公司 盐酸安妥沙星氯化钠注射液的配制方法

Also Published As

Publication number Publication date
WO2011063605A1 (fr) 2011-06-03

Similar Documents

Publication Publication Date Title
AP957A (en) Novel stable liquid paracetamol compositions, and method for preparing same.
CA2559630C (fr) Preparation contenant du fasudil et procede pour ameliorer la stabilite de celle-ci
CA2378424C (fr) Composition de sel de cuisine a base de moxifloxacine
Vermeire et al. Stability and compatibility of morphine
CN106963759B (zh) 用于治疗过度增生性疾病、自身免疫性疾病和心脏病的包含3-奎宁环酮衍生物的水溶液
JP4929352B2 (ja) 注入可能なパラセタモール液剤
CN101455631B (zh) 环磷腺苷葡胺注射液及其制备工艺
US20220378077A1 (en) Ready-To-Use Parenteral Nutrition Formulation
KR20020081293A (ko) 페메트렉시드를 모노티오글리세롤 ｌ-시스테인 또는티오글리콜산과 함께 포함하는 제약 조성물
CA2378425C (fr) Formulation pharmaceutique aqueuse de moxifloxacine ou de ses sels
CN102018663A (zh) 一种化合物/葡萄糖制剂
MX2007012166A (es) Composiciones y administracion de stannsoporfina.
CZ20023849A3 (cs) Nové farmaceutické prostředky na bázi alfa-(2,4-disulfofenyl)-N-terc. butylnitronu
CN102018664A (zh) 一种化合物/氯化钠制剂
JP2000178181A (ja) 微量元素製剤
CN107510650B (zh) 一种匹多莫德口服溶液及其制备方法
CN100516071C (zh) 头孢类化合物的氨丁三醇盐及其制备方法
JP2006083164A (ja) 輸液製剤
CN110314132B (zh) 一种门冬氨酸鸟氨酸注射液及其制备方法
CN102727429B (zh) 改善稳定性的匹多莫德注射液及其制备方法
CN101569612A (zh) 一种克林霉素磷酸酯冻干粉针试剂
CN107854486A (zh) 供注射用的多种微量元素的药物组合物及其用途
WO2024027549A1 (fr) Composition pharmaceutique contenant un inhibiteur de sécrétion d'acide gastrique pyrrole et son procédé de préparation
CN103446158B (zh) 盐酸头孢甲肟和小儿复方氨基酸注射液的药物组合物
CN108653259A (zh) 多种微量元素ⅳ的药物组合物及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110420